Supplement your learning on Ultrasound in uterine malformations and pathology

Join us for this engaging and informative course. Together with a panel of expert speakers from around the world, they will dive into the latest discourse surrounding Ultrasound in uterine malformations and pathology. This course offers attendees a valuable opportunity to gain a comprehensive understanding of the new advances in this area and learn how to apply them in practical situations.

Learning Objectives Malformations:

  • Understand embryology and classification of uterine malformations.
  • Identify uterine anomalies using 2D and 3D ultrasound.
  • Differentiate between different types of uterine anomalies.
  • Correlate ultrasound findings with MRI and clinical implications.
  • To learn apply knowledge to infertility, obstetric outcomes, and management decisions.

Learning Objectives Pathology:

  • Develop expertise in the ultrasound evaluation of endometrial pathology 
  • Gain expertise in ultrasound diagnosis of myometrial pathology 
  • Learn to differentiate benign from malignant uterine findings 
  • Enhance understanding of the management of symptomatic and asymptomatic women with sonographic findings in the uterus 
  • Gain skills in addressing diagnostic and management challenges in uterine pathology 
  • Expand knowledge of the roles of fibroids, adenomyosis, and endometrial pathology in infertility 
  • Understand the complementary roles of ultrasound and MRI in diagnosing adenomyosis 

Explore the topic before you attend our course

In order to make the most of this learning experience and help you achieve your learning objectives, we have prepared a path to guide you from the essentials to our course’s topics through ISUOG resources. The material below, will take you from the most basics to a more comprehensive view of Fetal Growth Restriction: From AI-Powered Prediction to Precision Medicine, some open to everyone and some available only to ISUOG members –some may even grant you CME points:
Some of these activities are exclusively available to our members. Become a member today.

ISUOG Guideline

ISUOG Consensus Statement on sonographic assessment of the endometrium: how to perform a gynecological ultrasound scan and report the findings

T.  Van den Bosch, R.  Heremans, C.  Landolfo, E.  Epstein, F. P. G.  Leone, T.  Bourne, D. Timmerman, Collaborators

First published: 16 January 2026

VISUOG

Hemi-uterus.png

Hemi-uterus

The development of a hemi-uterus, also called unicornuate uterus, is due to complete or partial agenesis of a unilateral Mullerian duct.

Septate Uterus Image.png

Septate Uterus

Septate uterus is a congenital uterine anomaly due to defective resorption of the medial fusion of the Müllerian ducts. The uterus has a normal external uterine morphology and a septum dividing the uterine cavity. It is further classified as partial or complete septate uterus.

bicorporeal uterus.jpg

Bicorporeal uterus

Bicorporeal uterus is characterized by the presence of an external indentation at the fundal midline that is greater than 50% of the thickness of the uterine wall.

dysmorphic.png

Dysmorphic Uterus

 A dysmorphic uterus includes subtypes T-shaped uterus and infantile uterus. It can be acquired or congenitally present.

uterine fibroids.png

Uterine fibroids

Uterine fibroids, also called myomas or leiomyomas, are benign fibromuscular tumours of the myometrium.

Picture1.png

Adenomyosis

Sonographic features considered typical for adenomyosis are echogenic subendometrial lines and buds, hyperechogenic islands, myometrial cysts, fan‐shaped shadowing, an irregular or interrupted junctional zone, translesional vascularity, asymmetrical thickening of the myometrium, and/or an enlarged globular uterus.

Intra-uteirne adhesions.jpg

Intrauterine adhesions

Intrauterine adhesions (IUA) are defined as abnormal fibrous bands bridging opposing sides of the endometrial cavity, causing obliteration and obstruction of the cavity and/or cervical canal.

Main Image.jpg

Endometrial Cancer

Endometrial cancer is the most common malignancy of the female genital tract, affecting 2-3% of women during their lifetime. The median age at diagnosis is 60-65 years and the most commonly associated risk-factor is obesity.

Uterine Sarcomas.png

Uterine sarcomas

Uterine sarcomas are rare malignant tumors arising from the mesenchymal tissues of the uterus, i.e. the endometrial stroma, uterine muscle and connective tissue. They represent 1% of female genital tract malignancies and 3-7% of all uterine malignances.

Metastatic.png

Uterine and endometrial masses from other primary tumors

Extragenital primary tumors that metastasize to the endometrium and or uterine cervix are infrequent conditions and represent a diagnostic challenge among clinicians and pathologists.

 

Patient Information

Septate Uterus

This leaflet is to help you understand what Septate Uterus is, what tests you need, and the implication of being diagnosed for you.

Hemi-uterus

This leaflet is to help you understand what Hemi-uterus is, how does it happen, what tests you need and what are the long term implications of the diagnosis.

Bicorporeal uterus

This leaflet is to help you understand what Bicorporeal uterus is, how does it happen, what tests you need and what are the long term implications of the diagnosis.

Uterine Fibroids

This leaflet is to help you understand what Uterine Fibroids are, the associated symptoms, and what treatments are available to you.

Adenomyosis

This leaflet is to help you understand what adenomyosis is, what tests you need, and the implication of being diagnosed for you and your baby.

Intrauterine Adhesions

This leaflet is to help you understand what intrauterine Adhesion is, what tests you need, and the implication of being diagnosed.

Endometrial hyperplasia

This leaflet is to help you understand what endometrial hyperplasia is, what tests you need and the implication of being diagnosed, and how it can be treated.

Endometrial Cancer

This leaflet is to help you understand what endometrial cancer is and what causes it, how it can be diagnosed and the treatments available to you.

 

UOG Articles

Endometrial assessment in abnormal uterine bleeding: transvaginal ultrasound alone may not be good enough

S. Nijjar, S. Kastora, A. Bajrami, S. Solangon, M. Widschwendter, D. Jurkovic

First published: 04 November 2025

 

Ultrasound features using MUSA terms and definitions in uterine sarcoma and leiomyoma: cohort study

C. De Bruyn, J. Ceusters, K. Vanden Brande, S. Timmerman, W. Froyman, D. Timmerman, A.-S. Van Rompuy, A. Coosemans, T. Van den Bosch

First published: 16 November 2023

 

ASRM Müllerian Anomalies Classification 2021: a critical review

A. Ludwin, S. Tudorache, W. P. Martins

First published: 09 June 2022

 

Consensus on revised definitions of Morphological Uterus Sonographic Assessment (MUSA) features of adenomyosis: results of modified Delphi procedure

M. J. Harmsen, T. Van den Bosch, R. A. de Leeuw, M. Dueholm, C. Exacoustos, L. Valentin, W. J. K. Hehenkamp, F. Groenman, C. De Bruyn, C. Rasmussen, L. Lazzeri, L. Jokubkiene, D. Jurkovic, J. Naftalin, T. Tellum, T. Bourne, D. Timmerman, J. A. F. Huirne

First published: 29 September 2021

 

Definition, prevalence, clinical relevance and treatment of T-shaped uterus: systematic review

M. A. Coelho Neto, A. Ludwin, F. Petraglia, W. P. Martins

First published: 08 September 2020

 

Septate uterus according to ESHRE/ESGE, ASRM and CUME definitions: association with infertility and miscarriage, cost and warnings for women and healthcare systems

A. Ludwin, I. Ludwin, M. A. Coelho Neto, C. O. Nastri, B. Bhagavath, S. R. Lindheim, W. P. Martins

First published: 11 April 2019

 

Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma

M. Ludovisi, F. Moro, T. Pasciuto, S. Di Noi, S. Giunchi, L. Savelli, M. A. Pascual, P. Sladkevicius, J. L. Alcazar, D. Franchi, R. Mancari, M. C. Moruzzi, D. Jurkovic, V. Chiappa, S. Guerriero, C. Exacoustos, E. Epstein, F. Frühauf, D. Fischerova, R. Fruscio, F. Ciccarone, G. F. Zannoni, G. Scambia, L. Valentin, A. C. Testa

First published: 25 March 2019

 

Videos

Diagnosis of uterine malformations

P. Bortoletto 2025

Differentiating fiboids from sarcomas

A. Testa 2023

What we have learnt from the IETA trial: the appearances associated with different kinds of endometrial pathology

T. Van den Bosch 2023

Diagnosing adenomyosis: what is its clinical relevance and how to treat it

T. Tellum 2023

Gynecological problems associated with Caesarean section scars: when and how do you intervene?

J. Huirne 2023

 

Share